Abstract
Cardiotoxicity promotes an increase in reactive oxygen species, inflammation, apoptosis, cardiac fibrosis, and these remain the main problems in the treatment of Cancer patients using doxorubicin. These associated processes induce myocardial dysfunction, decreasing the left ventricular ejection fraction, generating long-term heart failure. Some treatments have been described as attenuatin…